Thermo Fisher Scientific TMO Specialty Diagnostics — Segment assets
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Thermo Fisher Scientific in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Thermo Fisher Scientific's specialty diagnostics — segment assets.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Thermo Fisher Scientific's specialty diagnostics — segment assets?
- Thermo Fisher Scientific (TMO) reported specialty diagnostics — segment assets of $1.33B in Q1 2026.
- How has Thermo Fisher Scientific's specialty diagnostics — segment assets changed year-over-year?
- Thermo Fisher Scientific's specialty diagnostics — segment assets increased by 2.6% year-over-year, from $1.3B to $1.33B.
- What does specialty diagnostics — segment assets mean?
- This metric represents the total book value of assets specifically allocated to the Specialty Diagnostics operating segment. It encompasses the resources, including inventory, equipment, and intangible assets, utilized to support the development and distribution of diagnostic products. Monitoring this balance helps assess the capital intensity required to maintain the segment's market position.